Sandoz Group reported higher sales for the second quarter, driven by a strong performance in its biosimilar segment and a return to growth in generics.
Source link
Sandoz Shares Climb After Biosimilar Sales Drive Growth
Date:
More like thisRelated
Honda Doubles Profit, Lifts Guidance on Weak Yen
The Japanese automaker is aiming to improve its hybrid...
Swimmer le Clos says his home was destroyed in a fire while he was at the Commonwealth Games
CAPE TOWN, South Africa -- Olympic champion swimmer Chad...
Rep. Chuck Edwards abandons reelection bid after ethics panel report released
Rep. Chuck Edwards abandons reelection bid after ethics panel...